FOXO4 (forkhead box O4) – 10MG per vial

Clinical Test Expectation – FOXO4 – 10mg – Human Subjects : Aids age-related degenerative diseases. Enhanced wound healing and tissue repair. Life extension and healthspan improvement. Tissue Regeneration, Regulate insulin signaling. Induces targeted apoptosis of senescent cells
Strength – 10mg per vial

Detailed Product Information

FOXO4-DRI is a synthetic peptide, which is a sequence of amino acids synthesized in a laboratory, intended to imitate and interfere with natural biological functions. The term “FOXO4” pertains to Forkhead box protein O4, which is a member of the FOXO protein family. This family of proteins serves as transcription factors and is involved in various cellular processes, including metabolism, cell growth, proliferation, stress response, and programmed cell death. The acronym “DRI” signifies “D-Retro-Inverso,” a modification that reverses the arrangement of D-amino acids, thereby improving the peptide’s stability and its ability to penetrate cells. This design enables FOXO4-DRI to disrupt specific interactions associated with the natural FOXO4 protein, rather than merely inhibiting its function.

Dosing Details – Please visit this link for Dosing instructions : https://researchpeptides.co.za/dosage-instructions/